TY - JOUR
T1 - Bone-targeted therapy
AU - Salmen, J.
AU - Banys-Paluchowski, M.
AU - Fehm, T.
N1 - Publisher Copyright:
© 2015 Georg Thieme Verlag KG Stuttgart New York.
PY - 2015/6/10
Y1 - 2015/6/10
N2 - Bisphosphonates and denosumab are well established components of the therapy for osteoporosis and osseous metastases. Their relevance in the adjuvant situation for breast cancer patients is being discussed in part controversially due to the heterogeneous nature of the available data. In particular, it appears that post-menopausal women benefit from an adjuvant therapy with bisphosphonates. In the present contribution we discuss the clinical relevance of osteoprotective therapy in the metastatic and adjuvant settings. Above all the current AGO guidelines on osteo-oncology and bone health have been taken into consideration for recommendations to implement the available data.
AB - Bisphosphonates and denosumab are well established components of the therapy for osteoporosis and osseous metastases. Their relevance in the adjuvant situation for breast cancer patients is being discussed in part controversially due to the heterogeneous nature of the available data. In particular, it appears that post-menopausal women benefit from an adjuvant therapy with bisphosphonates. In the present contribution we discuss the clinical relevance of osteoprotective therapy in the metastatic and adjuvant settings. Above all the current AGO guidelines on osteo-oncology and bone health have been taken into consideration for recommendations to implement the available data.
UR - http://www.scopus.com/inward/record.url?scp=84946567367&partnerID=8YFLogxK
U2 - 10.1055/s-0035-1546151
DO - 10.1055/s-0035-1546151
M3 - Journal articles
AN - SCOPUS:84946567367
SN - 0016-5751
VL - 75
SP - 584
EP - 587
JO - Geburtshilfe und Frauenheilkunde
JF - Geburtshilfe und Frauenheilkunde
IS - 6
ER -
